To develop preventative, patient focused technology that delivers better health outcomes and more efficient care economics for type-2 diabetes.
HbA1c (glycated haemoglobin) checks indicate if someone has or is at risk of developing type-2 diabetes.
Frequent and regular HbA1c testing can confirm that therapeutic interventions and healthy lifestyle changes are working for people living with the condition.
There is currently no cost effective and reliable HbA1c self-test system available for measuring frequently and on demand.
THIS IS THE UNMET NEED.
Our diagnostic system will be the first to provide access to frequent and cost-effective HbA1c testing.
Partnered with a our Diabetes Management App, test results and trends will confirm that lifestyle changes and therapeutic interventions are working. This gives patients control and feedback that enables them to manage their condition more effectively.
The SmartCare System is a preventative solution that will delivery better patient health outcomes and more sustainable healthcare economics for the future.
An entrepreneurial engineer with a wide range of expertise and experience in product design and development, manufacturing, validation and business development. Board member of Med-tech and Bioprocessing companies.
A multi-award-winning scientist, entrepreneur, NED and philanthropist with over 20 years’ experience in the Pharmaceutical Industry spanning the large multi-nationals GlaxoSmithKline and Pfizer, virtual biotech and Contract Development and Manufacturing Organisations (CDMOs).
A CIMA qualified accountant with ample experience working across finance. Specialises in viability of investments, understanding profitability, sustainable cost control and presentation of financial data.
Dr Field is Associate Professor of diabetes & endocrinology at University of Surrey and honorary consultant endocrinologist at Surrey & Sussex Healthcare NHS Trust. He sits on the diabetes national specialty committee of NIHR Clinical Research Network.